Form 4 for DGX Quest Diagnostics
Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-18 · accession 0001955217-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-20 | 2026-02-18 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F - Tax | $208.48 | -511 | 8,173 | -6% | -$106.5K |
| D | 2026-02-20 | 2026-01-28 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L - Small Acq | $183.52 | +16 | 10.1K | +0.2% | +$2,936 |
| D | 2026-02-20 | 2026-02-18 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - Grant | $0.00 | +2,135 | 10.0K | +27% | $0 |
| D | 2026-02-20 | 2026-02-18 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - Grant | $0.00 | +9,853 | 9,853 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-18 | F | D | 259 | $206.99 | 7,914 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |
| 2 | Common | Common Stock | 2026-01-28 | L | A | 16 | $183.52 | 10,065 | D | — | — | (F3) Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. (F4) The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. |
| 3 | Common | Common Stock | 2026-02-18 | F | D | 252 | $210.01 | 8,173 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |
| 4 | Common | Common Stock | 2026-02-18 | A | A | 2,135 | $0.00 | 10,049 | D | — | — | (F2) Represents an award of restricted stock units. |
| 5 | Derivative | Non-Qualifed Stock Option (right to buy) | 2026-02-18 | A | A | 9,853 | $0.00 | 9,853 | D | $204.96 · — to 2036-02-18 | 9,853 Common Stock | (F6) The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. |